Clinical Trials in Detroit

Showing 6561-6580 of 14,997 trials

Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus

NCT03350035

This study will evaluate the effectiveness and safety of an investigational drug, IV ganaxolone, as adjunctive therapy to standard of care to treat subjects with status epilepticus.

Status EpilepticusConvulsive Status EPILEPTICUSNon Convulsive Status Epilepticus+1 more

Marinus Pharmaceuticals17 participantsStarted Feb 2018

Wilmington, Delaware, United States • Miami, Florida, United States • Atlanta, Georgia, United States +5 more locations

COMPLETEDPhase 3< 1 mile

Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure

NCT03759392

The purpose of this study is to evaluate the effect of treatment with omecamtiv mecarbil compared with placebo on exercise capacity as determined by cardiopulmonary exercise testing following 20 weeks of treatment with omecamtiv mecarbil or placebo

Heart Failure With Reduced Ejection Fraction

Cytokinetics276 participantsStarted Apr 2019

Anchorage, Alaska, United States • Little Rock, Arkansas, United States • Torrance, California, United States +78 more locations

Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus

Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure

Find Trials by Condition in Detroit

A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing Spondylitis

Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer

A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants

Allo vs Hypomethylating/Best Supportive Care in MDS (BMTCTN1102)

Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension

Gene Therapy for Achromatopsia (CNGB3)

A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)

Using Peer Support to Aid in Prevention and Treatment in Prediabetes

A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation

An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)

Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy

TAC Versus TC for Adjuvant Breast Cancer

An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas

Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS

A Phase 1 Study of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer

Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity

The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin Challenge

Achieving Diagnostic Excellence Through Prevention and Teamwork